Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1367644/000136764418000039/form8k_10252018.htm
January 2023
January 2023
December 2022
November 2022
September 2022
August 2022
August 2022
July 2022
June 2022
June 2022
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1367644/000136764418000039/form8k_10252018.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Emergent Biosolutions Inc..
Emergent Biosolutions Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: EBSEvents:
CIK: 1367644
Form Type: 8-K Corporate News
Accession Number: 0001367644-18-000039
Submitted to the SEC: Thu Oct 25 2018 9:15:48 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations